ART files Canadian license application for SoftScan breast imaging device

By Elaine Rigoli

Tampa, Fla., June 22 - ART Advanced Research Technologies, Inc. said it has filed a Medical Device Licence Application with Health Canada to begin the commercialization of its SoftScan breast-imaging device.

The granting of a license will allow ART to distribute the SoftScan device in Canada by certifying that the device is safe and effective and meets quality standards.

ART said it is seeking regulatory approval of SoftScan as an adjunct to X-ray mammography.

The system uses a non-invasive, pain-free approach based on time-domain optical imaging technology that enables the characterization of breast tumors by clinicians as benign or malignant, without exposing the patients to potentially harmful radiation.

ART is a medical-device company located in Saint-Laurent, Quebec.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.